Results 31 to 40 of about 2,119 (184)

COMPLEX THERAPY OF CHILDREN WITH MUCOVISCIDOSIS. RECOMMENDATIONS OF A PEDIATRICIAN

open access: yesПедиатрическая фармакология, 2006
Treatment of children's mucoviscidosis is a multicomponent complex of medical and non medicamental types of therapy. The earlier the basic mucoviscidosis treatment has started, the more favourable the diagnosis for the patient will be.
O.I. Simonova
doaj   +2 more sources

Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis [PDF]

open access: yes, 2015
Background: Cystic fibrosis is an inherited recessive disorder of chloride transport that is characterised by recurrent and persistent pulmonary infections from resistant organisms that result in lung function deterioration and early mortality in ...
Adeboyeku   +70 more
core   +4 more sources

ROLE OF THE KNOWN MUCOLYTICS IN MUCOVISCIDOSIS THERAPY

open access: yesПедиатрическая фармакология, 2014
The primary objective in the mucoviscidosis therapy is to ensure normal rheology of respiratory secretion for effective evacuationthereof from the bronchial tree and nasal sinuses.
O. I. Simonova, Yu. V. Gorinova
doaj   +1 more source

Making It Last: Storage Time and Temperature Have Differential Impacts on Metabolite Profiles of Airway Samples from Cystic Fibrosis Patients. [PDF]

open access: yes, 2017
Metabolites of human or microbial origin have the potential to be important biomarkers of the disease state in cystic fibrosis (CF). Clinical sample collection and storage conditions may impact metabolite abundances with clinical relevance.
John J. LiPuma   +5 more
core   +3 more sources

VIRAL INFECTIONS IN CHILDREN SUFFERED FROM CISTIC FIBROSIS

open access: yesПедиатрическая фармакология, 2011
Results of study of antiviral immunity indicators in patients with mucoviscidosis were presented. A significant antibody deficiency against a number of antigenically unrelated viruses — acute respiratory pathogens and Мycoplasma pneumonia, significantly ...
N.N. Nisevich   +5 more
doaj   +2 more sources

Severe liver dysfunction in an infant with cystic fibrosis masquerading as metabolic liver disease

open access: yesIndian Journal of Pathology and Microbiology, 2016
We present a rare presentation of cystic fibrosis with neonatal cholestasis. Histological features of mucoviscidosis were present in liver involving the biliary tract, intestinal mucosa, pancreas, and lung.
K P Srikanth   +3 more
doaj   +1 more source

Cystás fibrosisban szenvedő betegek életminőségének felmérése Magyarországon [PDF]

open access: yes, 2013
Bevezetés: A cystás fibrosis progresszív genetikai betegség, amely korlátozhatja a betegek mindennapi életét, befolyásolja életminőségüket. Célkitűzés: A szerzők célul tűzték ki a hazai cystás fibrosisban szenvedő betegek életminőségének felmérését ...
Bodnár, Réka   +9 more
core   +1 more source

Histopathological effects of Doxorubicin on pancreas in male Albino rats [PDF]

open access: yesIraqi Journal of Veterinary Sciences, 2015
The aim of this study was to investigate the histopathological side effects of doxorubicin on pancreas tissue in male albino rats Rattus norvegicus. This study were used 55 adult rats (2.5-3.5) month of age.
I.A. Ali, H.J. Jumaa, H.Kh. Ismael
doaj   +3 more sources

Estudo da freqüência de diabetes mellitus e intolerância à glicose em pacientes com fibrose cística Study of the frequency of diabetes mellitus and glucose intolerance in patients with cystic fibrosis

open access: yesJornal de Pediatria, 2001
OBJETIVO: avaliar a freqüência de diabetes mellitus (DM) e de intolerância à glicose nos pacientes com fibrose cística seguidos no Serviço de Gastropediatria do HC-FMRP-USP.
Flávia A.A. de Castro   +3 more
doaj   +1 more source

A Multicenter Screening Study [PDF]

open access: yes, 2014
Background In cystic fibrosis, highly variable glucose tolerance is suspected. However, no study provided within-patient coefficients of variation.
Ballmann, Manfred   +6 more
core   +1 more source

Home - About - Disclaimer - Privacy